Cagri / GLP-1 – 20mg
$300.00
Cagri/GLP-1 20mg
Cagri/GLP-1 is a novel peptide that is being researched for its potential role in weight management and metabolic health. It is a combination of two peptides: the GLP-1 receptor agonist and the amylin analog, which are both being studied for their synergistic effects on appetite regulation, blood sugar control, and fat loss.
Potential Research Applications
- Appetite Regulation and Satiety: Studied for its dual mechanism in reducing appetite and promoting satiety, potentially aiding in long-term weight management.
- Weight Loss and Fat Metabolism: Investigated for its potential to enhance fat oxidation and support metabolic health, making it a candidate for obesity research.
- Blood Sugar Control: Explored for its ability to regulate blood glucose levels and enhance insulin sensitivity, offering potential benefits for individuals with metabolic conditions like Type 2 diabetes.
- Insulin Sensitivity and Metabolic Health: Researched for its effects on improving overall metabolic health by balancing blood sugar levels and enhancing insulin response.
- Synergistic Peptide Effects: Examined for its combined impact on energy balance and metabolic rate, providing an innovative approach to managing weight and metabolic function.
✔ High-Quality Research Peptide – Produced under strict quality control standards.
✔ Lab-Tested for Purity – Ensuring consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Arrives in lyophilized (powder) form for maximum stability.
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
Cagri/GLP-1 is a combination of two peptides: Cagrilintide and GLP-1. GLP-1 is a GLP-1 receptor agonist that helps regulate blood sugar levels, reduce appetite, and promote weight loss in research. When combined with Cagrilintide, a synthetic peptide that mimics amylin to regulate hunger and improve metabolic health, Cagri/GLP-1 aims to provide enhanced weight loss and metabolic benefits.
The combination of these two peptides works synergistically. Cagrilintide slows gastric emptying, reduces food intake, and increases satiety, while GLP-1 helps control blood sugar levels and further reduces appetite. Together, they offer a comprehensive approach to weight management and improved insulin sensitivity in research studies.
More research is needed to fully understand its long-term safety, effectiveness, and potential applications in researching various metabolic conditions.
Research Use Only
No Certificate of Analysis images available for this product.
